Seoul Pharma Co (XKRX:018680) Total Liabilities : ₩31,448 Mil (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Seoul Pharma Co Total Liabilities?

Seoul Pharma Co's Total Liabilities for the quarter that ended in Dec. 2024 was ₩31,448 Mil.

Seoul Pharma Co's quarterly Total Liabilities declined from Jun. 2024 (₩28,410.21 Mil) to Sep. 2024 (₩27,737.09 Mil) but then increased from Sep. 2024 (₩27,737.09 Mil) to Dec. 2024 (₩31,448.16 Mil).

Seoul Pharma Co's annual Total Liabilities declined from Dec. 2022 (₩27,006.39 Mil) to Dec. 2023 (₩24,741.27 Mil) but then increased from Dec. 2023 (₩24,741.27 Mil) to Dec. 2024 (₩31,448.16 Mil).

Seoul Pharma Co Total Liabilities Historical Data

The historical data trend for Seoul Pharma Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seoul Pharma Co Total Liabilities Chart

Seoul Pharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

36,234.87

43,292.37

27,006.39

24,741.27

31,448.16

Seoul Pharma Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															24,741.27	25,152.14	28,410.21	27,737.09	31,448.16

Seoul Pharma Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Seoul Pharma Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14141.379	+	(12460.299	+	1132.289
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	3714.196	+	0)
	=	31,448

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	71620.145	-	40171.983
	=	31,448

Seoul Pharma Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14141.379	+	(12460.299	+	1132.289
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	3714.196	+	0)
	=	31,448

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	71620.145	-	40171.983
	=	31,448

Seoul Pharma Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Seoul Pharma Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Seoul Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Seoul Pharma Co Ltd (XKRX:018680) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

21, Banpo-daero, Seocho-gu, Seoul, KOR, 06710

Website

http://www.seoulpharma.com

Seoul Pharma Co Ltd is engaged in manufacturing and distribution of pharmaceuticals products in South Korea. Its products portfolio consists of drugs for the cardiovascular system, respiratory system, and digestive system, drugs for hypertension, antipyretics, drugs for skin disease, drugs for a cough as well as ointments, among others.

Seoul Pharma Co Headlines

No Headlines